4//SEC Filing
GENMAB A/S 4
Accession 0001193125-25-325265
$GMABCIK 0001651311other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 5:54 PM ET
Size
8.3 KB
Accession
0001193125-25-325265
Insider Transaction Report
Form 4
Merus N.V.MRUS
GENMAB A/S
10% Owner
Transactions
- Purchase
Common Shares, nominal value EUR 0.09 per share
2025-12-16$97.00/sh+120,752$11,712,944→ 71,583,829 total(indirect: See footnotes) - Purchase
Common Shares, nominal value EUR 0.09 per share
2025-12-17$97.00/sh+150,795$14,627,115→ 71,734,624 total(indirect: See footnotes)
Footnotes (2)
- [F1]On September 29, 2025, Genmab A/S ("Parent"), Genmab Holding II B.V., a wholly owned subsidiary of Parent ("Purchaser"), and the Issuer entered into a transaction agreement (the "Transaction Agreement"). Pursuant to the terms of the Transaction Agreement, Purchaser commenced a tender offer for all the issued and outstanding common shares, nominal value EUR 0.09 per share (the "Common Shares") of the Issuer (the "Offer"), and, on December 12, 2025, following the expiration of the initial offering period of the Offer (the "Expiration Time"), Purchaser accepted 71,463,077 Common Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Expiration Time, representing approximately 94.2% of the Issuer's outstanding Common Shares, in exchange for a cash payment equal to $97.00 per Common Share, without interest and less applicable withholding taxes.
- [F2]On December 12, 2025, Purchaser commenced a subsequent offering period during which Purchaser acquired an additional 120,752 Common Shares on December 16, 2025 and an additional 150,795 Common Shares on December 17, 2025. Parent, as the parent entity of Purchaser, beneficially owns the Common Shares held directly by Purchaser.
Documents
Issuer
Merus N.V.
CIK 0001651311
Entity typeother
Related Parties
1- filerCIK 0001434265
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 5:54 PM ET
- Size
- 8.3 KB